HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Premature Birth (Birth, Premature)

CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
Also Known As:
Birth, Premature; Premature Births; Preterm Birth; Birth, Preterm; Births, Premature; Births, Preterm; Preterm Births
Networked: 3473 relevant articles (153 outcomes, 622 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Birth Weight (Birth Weights)
2. Pre-Eclampsia (Preeclampsia)
3. Bacterial Vaginosis
4. Infection
5. Premature Obstetric Labor (Premature Labor)

Experts

1. Iams, Jay D: 40 articles (08/2015 - 03/2002)
2. Crowther, Caroline A: 38 articles (06/2015 - 11/2003)
3. Caritis, Steve N: 31 articles (11/2015 - 03/2002)
4. Menon, Ramkumar: 31 articles (11/2015 - 01/2006)
5. Mercer, Brian M: 29 articles (02/2015 - 03/2002)
6. Thorp, John M: 29 articles (02/2015 - 03/2002)
7. Rouse, Dwight J: 28 articles (12/2015 - 08/2007)
8. Wapner, Ronald J: 28 articles (06/2015 - 11/2002)
9. Romero, Roberto: 26 articles (12/2015 - 05/2003)
10. Goldenberg, Robert L: 26 articles (05/2015 - 03/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Premature Birth:
1. ProgesteroneFDA LinkGeneric
2. Adrenal Cortex Hormones (Corticosteroids)IBA
3. Fibronectins (Fibronectin)IBA
4. MagnesiumIBA
5. Folic Acid (Vitamin M)FDA LinkGeneric
6. Metronidazole (Metric)FDA LinkGeneric
7. Anti-Bacterial Agents (Antibiotics)IBA
8. Vitamin A (Retinol)FDA LinkGeneric
08/20/1999 - "Vitamin A supplementation, a low-cost intervention, does not appear to be effective in reducing overall mother-to-child transmission of HIV; however, its potential for reducing the incidence of preterm births, and the risk of mother-to-child transmission of HIV in these infants needs further investigation."
01/01/2015 - "1) Vitamin A alone versus placebo or no treatmentOverall, when trial results are pooled, vitamin A supplementation does not affect the risk of maternal mortality (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.65 to 1.20; four trials Ghana, Nepal, Bangladesh, UK, high quality evidence), perinatal mortality (RR 1.01, 95% CI 0.95 to 1.07; one study, high quality evidence), neonatal mortality, stillbirth, neonatal anaemia, preterm birth (RR 0.98, 95% CI 0.94 to 1.01, five studies, high quality evidence), or the risk of having a low birthweight baby.Vitamin"
01/01/2010 - " when trial results are pooled, Vitamin A supplementation does not affect the risk of maternal mortality (risk ratio (RR) 0.78, 95% confidence interval (CI) 0.55 to 1.10, 3 studies, Nepal, Ghana,UK ), perinatal mortality, neonatal mortality, stillbirth, neonatal anaemia, preterm birth or the risk of having a low birthweight baby. "
01/01/2002 - "There is no evidence of heterogeneity between the trials (p = 0.37), and no evidence of an effect of vitamin A supplementation in HIV-infected pregnant women on stillbirths (OR 1.07, 95% CI 0.63 to 1.80), very preterm births, i.e. "
01/01/2011 - "However, antenatal vitamin A supplementation significantly improved birth weight (3 trials, 1809 women: MD 89.78, 95%CI 84.73 to 94.83; I(2)=33.0%), but there was no evidence of an effect on preterm births (3 trials, 2110 women: RR 0.88, 95%CI 0.65 to 1.19; I(2)=58.1%), stillbirths (4 trials, 2855 women: RR 0.99, 95%CI 0.68 to 1.43; I(2)=0%), deaths by 24 months (2 trials, 1635 women: RR 1.03, 95%CI 0.88 to 1.20; I(2)=0%), postpartum CD4 levels (1 trial, 727 women: MD -4.00, 95% CI -51.06 to 43.06), and maternal death ( 1 trial, 728 women: RR 0.49, 95%CI 0.04 to 5.37). "
9. ZincIBA
10. Biological Markers (Surrogate Marker)IBA

Therapies and Procedures

1. Bed Rest (Bedrest)
2. Neonatal Intensive Care
3. Cervical Cerclage
4. Prenatal Care
5. Tocolysis